These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 29708744)

  • 41. Structural Basis for Negative Allosteric Modulation of GluN2A-Containing NMDA Receptors.
    Yi F; Mou TC; Dorsett KN; Volkmann RA; Menniti FS; Sprang SR; Hansen KB
    Neuron; 2016 Sep; 91(6):1316-1329. PubMed ID: 27618671
    [TBL] [Abstract][Full Text] [Related]  

  • 42. GluN2B-selective N-methyl-D-aspartate (NMDA) receptor antagonists derived from 3-benzazepines: synthesis and pharmacological evaluation of benzo[7]annulen-7-amines.
    Benner A; Bonifazi A; Shirataki C; Temme L; Schepmann D; Quaglia W; Shoji O; Watanabe Y; Daniliuc C; Wünsch B
    ChemMedChem; 2014 Apr; 9(4):741-51. PubMed ID: 24677663
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Surface Expression, Function, and Pharmacology of Disease-Associated Mutations in the Membrane Domain of the Human GluN2B Subunit.
    Vyklicky V; Krausova B; Cerny J; Ladislav M; Smejkalova T; Kysilov B; Korinek M; Danacikova S; Horak M; Chodounska H; Kudova E; Vyklicky L
    Front Mol Neurosci; 2018; 11():110. PubMed ID: 29681796
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Systematic variation of the benzoylhydrazine moiety of the GluN2A selective NMDA receptor antagonist TCN-201.
    Schreiber JA; Müller SL; Westphälinger SE; Schepmann D; Strutz-Seebohm N; Seebohm G; Wünsch B
    Eur J Med Chem; 2018 Oct; 158():259-269. PubMed ID: 30218911
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inhibition of Plasma Membrane Na/Ca-Exchanger by KB-R7943 or Lithium Reveals Its Role in Ca-Dependent N-methyl-d-aspartate Receptor Inactivation.
    Sibarov DA; Abushik PA; Poguzhelskaya EE; Bolshakov KV; Antonov SM
    J Pharmacol Exp Ther; 2015 Dec; 355(3):484-95. PubMed ID: 26391160
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Quantification of the Mg2+-induced potency shift of amantadine and memantine voltage-dependent block in human recombinant GluN1/GluN2A NMDARs.
    Otton HJ; Lawson McLean A; Pannozzo MA; Davies CH; Wyllie DJ
    Neuropharmacology; 2011; 60(2-3):388-96. PubMed ID: 20955720
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Interaction between positive allosteric modulators and trapping blockers of the NMDA receptor channel.
    Emnett CM; Eisenman LN; Mohan J; Taylor AA; Doherty JJ; Paul SM; Zorumski CF; Mennerick S
    Br J Pharmacol; 2015 Mar; 172(5):1333-47. PubMed ID: 25377730
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Preclinical Characterization of (
    Bristow LJ; Gulia J; Weed MR; Srikumar BN; Li YW; Graef JD; Naidu PS; Sanmathi C; Aher J; Bastia T; Paschapur M; Kalidindi N; Kumar KV; Molski T; Pieschl R; Fernandes A; Brown JM; Sivarao DV; Newberry K; Bookbinder M; Polino J; Keavy D; Newton A; Shields E; Simmermacher J; Kempson J; Li J; Zhang H; Mathur A; Kallem RR; Sinha M; Ramarao M; Vikramadithyan RK; Thangathirupathy S; Warrier J; Islam I; Bronson JJ; Olson RE; Macor JE; Albright CF; King D; Thompson LA; Marcin LR; Sinz M
    J Pharmacol Exp Ther; 2017 Dec; 363(3):377-393. PubMed ID: 28954811
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Disease-associated nonsense and frame-shift variants resulting in the truncation of the GluN2A or GluN2B C-terminal domain decrease NMDAR surface expression and reduce potentiating effects of neurosteroids.
    Kysilov B; Kuchtiak V; Hrcka Krausova B; Balik A; Korinek M; Fili K; Dobrovolski M; Abramova V; Chodounska H; Kudova E; Bozikova P; Cerny J; Smejkalova T; Vyklicky L
    Cell Mol Life Sci; 2024 Jan; 81(1):36. PubMed ID: 38214768
    [TBL] [Abstract][Full Text] [Related]  

  • 50. On mechanism of allosteric modulation of NMDA receptor via amino-terminal domains.
    Karlov DS; Radchenko EV; Zefirov AN; Palyulin VA; Pentkovski VM; Zefirov NS
    Biochem Biophys Res Commun; 2012 Aug; 424(4):687-90. PubMed ID: 22789854
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pregnane-based steroids are novel positive NMDA receptor modulators that may compensate for the effect of loss-of-function disease-associated GRIN mutations.
    Kysilov B; Hrcka Krausova B; Vyklicky V; Smejkalova T; Korinek M; Horak M; Chodounska H; Kudova E; Cerny J; Vyklicky L
    Br J Pharmacol; 2022 Aug; 179(15):3970-3990. PubMed ID: 35318645
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sensitivity of N-methyl-D-aspartate receptor-mediated excitatory postsynaptic potentials and synaptic plasticity to TCN 201 and TCN 213 in rat hippocampal slices.
    Izumi Y; Zorumski CF
    J Pharmacol Exp Ther; 2015 Feb; 352(2):267-73. PubMed ID: 25413830
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The GluN2B subunit represents a major functional determinant of NMDA receptors in human induced pluripotent stem cell-derived cortical neurons.
    Neagoe I; Liu C; Stumpf A; Lu Y; He D; Francis R; Chen J; Reynen P; Alaoui-Ismaili MH; Fukui H
    Stem Cell Res; 2018 Apr; 28():105-114. PubMed ID: 29454156
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Coumarin-3-carboxylic acid derivatives as potentiators and inhibitors of recombinant and native N-methyl-D-aspartate receptors.
    Irvine MW; Costa BM; Volianskis A; Fang G; Ceolin L; Collingridge GL; Monaghan DT; Jane DE
    Neurochem Int; 2012 Sep; 61(4):593-600. PubMed ID: 22265875
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Synthesis and in vitro characterisation of ifenprodil-based fluorescein conjugates as GluN1/GluN2B N-Methyl-D-aspartate receptor antagonists.
    Dhilly M; Becerril-Ortega J; Colloc'h N; MacKenzie ET; Barré L; Buisson A; Nicole O; Perrio C
    Chembiochem; 2013 Apr; 14(6):759-69. PubMed ID: 23532918
    [TBL] [Abstract][Full Text] [Related]  

  • 56. An Integrated Approach for Screening and Identification of Positive Allosteric Modulators of N-Methyl-D-Aspartate Receptors.
    Jambrina E; Cerne R; Smith E; Scampavia L; Cuadrado M; Findlay J; Krambis MJ; Wakulchik M; Chase P; Brunavs M; Burris KD; Gallagher P; Spicer TP; Ursu D
    J Biomol Screen; 2016 Jun; 21(5):468-79. PubMed ID: 26838761
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Novel Mode of Antagonist Binding in NMDA Receptors Revealed by the Crystal Structure of the GluN1-GluN2A Ligand-Binding Domain Complexed to NVP-AAM077.
    Romero-Hernandez A; Furukawa H
    Mol Pharmacol; 2017 Jul; 92(1):22-29. PubMed ID: 28468946
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Spermidine and Ca(2+), but not Na(+), can permeate NMDA receptors consisting of GluN1 and GluN2A or GluN2B in the presence of Mg(2+).
    Hirose T; Saiki R; Yoshizawa Y; Imamura M; Higashi K; Ishii I; Toida T; Williams K; Kashiwagi K; Igarashi K
    Biochem Biophys Res Commun; 2015 Aug; 463(4):1190-5. PubMed ID: 26086092
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Neuroactive Steroid
    La DS; Salituro FG; Martinez Botella G; Griffin AM; Bai Z; Ackley MA; Dai J; Doherty JJ; Harrison BL; Hoffmann EC; Kazdoba TM; Lewis MC; Quirk MC; Robichaud AJ
    J Med Chem; 2019 Aug; 62(16):7526-7542. PubMed ID: 31390523
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Neto1 associates with the NMDA receptor/amyloid precursor protein complex.
    Cousins SL; Innocent N; Stephenson FA
    J Neurochem; 2013 Sep; 126(5):554-64. PubMed ID: 23621516
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.